Table 2: Ongoing lenalidomide (L) monotherapy trials.

NamePhaseAgeHistologyDrugsStatus

NCT00875667II>18 ysRelapsed or refractory MCLLOngoing and recruiting
NCT00737529II>18 ysRelapsed or refractory MCLLOngoing and recruiting
NCT00179673II>18 ysRelapsed or refractory indolent NHLLTerminated

L: lenalidomide.